1. Patients launch $1.27 million crowdfunding campaign for ME/CFS gut microbiome study.
    Check out the website, Facebook and Twitter. Join in donate and spread the word!
9th Invest in ME International ME Conference, 2014 - Part 1: Autoimmunity and ME
Mark Berry begins a series of articles on the 9th Invest in ME International ME Conference in London, with a look at three presentations on autoimmunity
Discuss the article on the Forums.

BMJ debate: "Should journals stop publishing research funded by the drug industry?"

Discussion in 'Other Health News and Research' started by Dolphin, Jan 17, 2014.

  1. Dolphin

    Dolphin Senior Member

    Messages:
    6,816
    Likes:
    5,901
    Perhaps somebody could point out how research on non-pharmacological therapies e.g. CBT, GET, etc. isn't without its problems, perhaps using the PACE Trial as an example. Also, there is no yellow card scheme for reporting adverse reactions for such therapies, no central body (cf. FDA, European Medicines Agency) regulating the therapies, etc.
     
    Valentijn and leela like this.
  2. alex3619

    alex3619 Senior Member

    Messages:
    7,436
    Likes:
    11,850
    Logan, Queensland, Australia
    This is an issue that has concerned me for some time. Drug company research into the efficacy of their own products should be changed to independent analysis. This may mean setting up large independent research organizations that pharmaceutical companies pay, but which are closely regulated. I don't think merely not publishing results is enough.

    I also think there should be some kind of reporting method for problems with psychotherapy etc. The current system is broken or non-existent.
     
    WillowJ and Valentijn like this.
  3. taniaaust1

    taniaaust1 Senior Member

    Messages:
    8,061
    Likes:
    5,041
    Sth Australia
    But if drug company research wasnt published.. lots of helpful research wouldnt be out there either as they do fund so much research.

    What I believe should happen is that there should be something in place so that ALL proper studies are published and have to be whether postive or negative ones. At the moment a pharma company could do the same study over and over until they come up with a positive result (and we all know that negative studies often arent published and journals more likely to accept positive ones).

    Independant analyses like Alex mentions would be good for studies in which the ones funding them are going to end up profiting from them.
     

See more popular forum discussions.

Share This Page